ORLANDO, Fla., Sept. 30, 2009 (GLOBE NEWSWIRE) -- RedChip Visibility, a division of RedChip Companies, Inc., has initiated coverage on Imagenetix Inc. (OTCBB:IAGX), an innovator of scientifically tested, natural-based, proprietary, bioceutical products developed to enhance human health on a global basis.
Harry Russell, MBA, RedChip Research Analyst, reported:
"Imagenetix is a neutraceutical company with a suite of proprietary, scientifically tested, validated, and naturally based products. The Company's main focus is on anti-inflammation; and, its lead product, Celadrin(R), is being strategically positioned with mass marketers. With the existing traction that the Company has with Celadrin, there should be substantial operating leverage going forward and a more seamless positioning of the Company's other products.
The Company is well-positioned in very large markets; and, although these markets are competitive, most of the challenges that are presented to new entrants are behind them. Finally, because of their large distribution capabilities, revenue growth can be generated in a very short period of time.
Because the Company has its most challenging days behind it and, further, because of the validation they have earned with large vendor organizations, we feel now is a critical time for investment. For this reason, we are initiating coverage of IAGX with a 'Speculative Buy' recommendation and a 12-month price target of $1.25."
To receive a complimentary copy of the RedChip Visibility Initial Research Report for IAGX, please visit: http://www.redchip.com/about/aboutmain.asp?page=vreport&reportid=194&from=pr9282009
To learn more about Imagenetix, Inc., visit: http://www.redchip.com/visibility/investor.asp?symbol=IAGX
About Imagenetix
Imagenetix, Inc., based in San Diego, California, is an innovator of scientifically tested and proprietary bioceutical products. Imagenetix develops and formulates proprietary, over-the-counter topical creams, skincare products and nutritional supplements to be marketed globally through multiple channels of distribution. In addition, the company develops patentable compounds for entering into licensing agreements with pharmaceutical partners. Imagenetix is the creator of InflameAway Celadrin(R). Please visit, www.celadrin.com or www.imagenetix.net.
About RedChip Companies, Inc.
RedChip Companies is an international, small-cap research and financial public relations firm headquartered in Orlando, Florida; with affiliate offices in Paris and Qingdao, China. RedChip delivers concrete, measurable results for its clients through its extensive national and international network of small-cap institutional and retail investors. RedChip has developed the most comprehensive platform of products and services for small-cap companies, including: RedChip Research(tm), Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences, RedChip Small-Cap TV(tm), Social Media Services, and RedChip Radio(tm). To learn more about RedChip's products and services please visit: http://www.redchip.com/visibility/productsandservices.asp.
The RedChip Companies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2761
Disclosure
The analysts contributing to this report do not hold any shares of Imagenetix, Inc. ("IAGX"). RedChip certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analyst in the report. The equity research report(s) are not a recommendation of a solicitation to purchase or sell any security, nor do they constitute investment advice. IAGX is a client of RedChip Companies, Inc. and of RedChip Visibility, a division of RedChip Companies. IAGX agreed to pay RedChip Visibility a fee of thirty-six thousand dollars in cash for twelve (12) months of RedChip Visibility Program services, which includes the preparation of the equity research report(s). The equity research report(s) are prepared for informational purposes only and are paid for by the company portrayed in the report. The equity research report(s) are not a recommendation of a solicitation to purchase or sell any security, nor do they constitute investment advice. RedChip Companies, Inc., is currently engaged by this company to provide investor awareness services. Investor awareness services and programs are designed to help small-cap companies communicate their investment characteristics. These services may include investor conferences, digital and print distribution of IAGX investor-related materials and radio programming. RedChip Companies, Inc., employees and affiliates may have positions and affect transactions in the securities or options of the issuers mentioned herein.